Could a neck implant be the lifeline heart failure patients need?

NCT ID NCT07232030

ENROLLING_BY_INVITATION Disease control Sponsor: CVRx, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 10 times

Summary

This study tests a device called Barostim that stimulates nerves in the neck to help the heart work better. It involves 2,500 adults with moderate heart failure who still have symptoms despite standard treatments. The goal is to see if the device reduces deaths and hospital stays compared to usual care alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure mild heart failure moderate heart failure systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE HEART FAILURE NYHA CLASS II HEART FAILURE NYHA CLASS III

Contacts and locations

Locations

BayCare Health System

Clearwater, Florida, 33756, United States
BayCare Health Systems

Tampa, Florida, 33614, United States
CHRISTUS Trinity Mother Frances

Tyler, Texas, 75701, United States
Cardiology Associates of Mobile

Mobile, Alabama, 36608, United States
Erlanger Health

Chattanooga, Tennessee, 37403, United States
First Coast Cardiovascular Institute

Jacksonville, Florida, 32256, United States
North Central Heart

Sioux Falls, South Dakota, 57108, United States
Tallahassee Research Institute

Tallahassee, Florida, 32308, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.